tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 108 are a BUY (85.71%), 16 are a HOLD (12.7%), 2 are a SELL (1.59%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 46.46% that have a potential upside of 96.08% achieved within 147 days.
Bruce Jackson’s has documented 233 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUMA, Humacyte at 10-Oct-2024.
Analyst best performing recommendations are on CLNN (CLENE .).
The best stock recommendation documented was for CLNN (CLENE .) at 5/23/2024. The price target of $5 was fulfilled within 49 days with a profit of $4.65 (1328.57%) receiving and performance score of 271.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years 3 months 14 days ago
(22-Jul-2021)
1/1 (100%)
$6.31 (110.90%)
484
Buy
$10
$9.54 (2073.91%)
$8
3 years 11 months 2 days ago
(03-Dec-2020)
0/3 (0%)
$4.16 (59.27%)
Buy
4 years 4 months 19 days ago
(17-Jun-2020)
2/2 (100%)
$1.27 (34.05%)
165
Buy
$12
$11.54 (2508.70%)
$9
4 years 6 months 20 days ago
(16-Apr-2020)
4/4 (100%)
$2.83 (60.84%)
188
Which stock is Bruce Jackson is most bullish on?
Which stock is Bruce Jackson is most reserved on?
What Year was the first public recommendation made by Bruce Jackson?
